Literature DB >> 25131924

MicroRNA-29b promotes high-fat diet-stimulated endothelial permeability and apoptosis in apoE knock-out mice by down-regulating MT1 expression.

Hua-Qing Zhu1, Qing li2, Liu-Yi Dong3, Qing Zhou2, Hua Wang4, Yuan Wang2.   

Abstract

BACKGROUND: High-fat diet has been reported to be associated with cardiovascular diseases which is implicated in atherosclerosis. However, the underlying mechanisms remain unknown. MicroRNAs (miRNAs) are non-coding small RNAs that control gene expression at the post-transcriptional level. Dysregulated miRNAs have been shown to be involved in atherosclerosis. METHODS AND
RESULTS: This study examined whether microRNA-29b (miR-29b) regulates high-fat diet induced endothelial permeability and apoptosis by targeting MT1, a known melatonin membrane receptor. In apoE knock-out mice, a high-fat diet increased miR-29b expression and induced apoptosis as determined by up-regulation of caspase-3 activity. However, a standard diet did not alter apoptosis. miR-29b antagomir decreased endothelial permeability and apoptosis in high-fat diet-stimulated mice. In contrast, a miR-29b mimic enhanced endothelial permeability and apoptosis. The induction of miR-29b correlated with a reduction in Bcl-2 and MT1 in high-fat diet-stimulated mice. miR-29b have an effect on the marker of inflammation (NF-κB) and cell adhesion molecule (ICAM-1). We further showed that miR-29b targeted and inhibited MT1 expression through a target site located in the 3'un-translational region of MT1 mRNA. This study demonstrates a role of miR-29b in atherosclerosis and identifies MT1 as a direct target of miR-29b.
CONCLUSIONS: The effect of miR-29b on endothelial permeability and apoptosis is mediated through the down-regulation of MT1. Thus, miR-29b may be a new therapeutic target for atherosclerosis.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; High-fat diet; MT1; MicroRNA-29b; Permeability

Mesh:

Substances:

Year:  2014        PMID: 25131924     DOI: 10.1016/j.ijcard.2014.07.095

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  17 in total

Review 1.  Melatonin receptors: molecular pharmacology and signalling in the context of system bias.

Authors:  Erika Cecon; Atsuro Oishi; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

Review 2.  Effects of melatonin on cardiovascular risk factors and metabolic syndrome: a comprehensive review.

Authors:  Mohsen Imenshahidi; Golamreza Karimi; Hossein Hosseinzadeh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-01-30       Impact factor: 3.000

Review 3.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

4.  Melatonin activity and receptor expression in endometrial tissue and endometriosis.

Authors:  A A Mosher; M W Tsoulis; J Lim; C Tan; S K Agarwal; N A Leyland; W G Foster
Journal:  Hum Reprod       Date:  2019-07-08       Impact factor: 6.918

Review 5.  The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases.

Authors:  Seth Mikaye Monayo; Xin Liu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

6.  MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis.

Authors:  Yong Zhang; Wei Qin; Longyin Zhang; Xianxian Wu; Ning Du; Yingying Hu; Xiaoguang Li; Nannan Shen; Dan Xiao; Haiying Zhang; Zhange Li; Yue Zhang; Huan Yang; Feng Gao; Zhimin Du; Chaoqian Xu; Baofeng Yang
Journal:  Sci Rep       Date:  2015-03-24       Impact factor: 4.379

7.  Systematic Identification and Bioinformatic Analysis of MicroRNAs in Response to Infections of Coxsackievirus A16 and Enterovirus 71.

Authors:  Zheng Zhu; Yuhua Qi; Huan Fan; Lunbiao Cui; Zhiyang Shi
Journal:  Biomed Res Int       Date:  2016-10-24       Impact factor: 3.411

8.  The Ticking of the Epigenetic Clock: Antipsychotic Drugs in Old Age.

Authors:  Adonis Sfera; Carolina Osorio; Luzmin Inderias; Michael Cummings
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-31       Impact factor: 5.555

9.  MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction.

Authors:  Maskomani Silambarasan; Jun Rong Tan; Dwi Setyowati Karolina; Arunmozhiarasi Armugam; Charanjit Kaur; Kandiah Jeyaseelan
Journal:  Int J Mol Sci       Date:  2016-04-07       Impact factor: 5.923

Review 10.  Effects of melatonin on cardiovascular diseases: progress in the past year.

Authors:  Hang Sun; Aaron M Gusdon; Shen Qu
Journal:  Curr Opin Lipidol       Date:  2016-08       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.